As of Aug 28
| +0.79 / +0.84%|
The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 115.00, with a high estimate of 135.00 and a low estimate of 100.00. The median estimate represents a +21.00% increase from the last price of 95.04.
The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.